Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene vs 5-FU vs Imiquimod for Verruca Plana
NCT05314127Phase 2Unknown
- Sponsor
- Zagazig University
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tazarotene in verruca plana (VP), sponsored by Zagazig University. Status: unknown.
02
Drugs
tazarotene
03
Conditions
verruca plana (VP)
Beyond the preview
Go deeper on NCT05314127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314127.